T7	Subject 27 36	a patient
T8	Effect 11 23	elevated INR
T9	Treatment 40 48;55 95	warfarin increase in extended-release niacin dose
T11	Drug 40 48	warfarin
T12	Drug 84 90	niacin
T13	Dosage 55 66;91 95	increase in dose
T14	Severity_cue 0 10	Critically
T10	Adverse_event 49 54	after
E1	Adverse_event:T10 
A1	Severity E1 High